Processing 00000000.tx.1: Analysis of the Subsite Specificity of Rat Insulysin Using Fluorogenic Peptide Substrates* Eun-Suk Song, Atish Mukherjee, Maria Aparecida Juliano, Jan St. 

Phrase: "Analysis of the Subsite Specificity of Rat Insulysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fluorogenic Peptide Substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0016349:Fluorogenic Substrate [Indicator, Reagent, or Diagnostic Aid]
   793   C1710236:Substrate [Manufactured Object]

Phrase: "* Eun-Suk Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872005:Song [Intellectual Product]

Phrase: "Atish Mukherjee,"

Phrase: "Maria Aparecida Juliano,"

Phrase: "Jan St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]
Processing 00000000.tx.2: Pyrek, Jack P. 

Phrase: "Pyrek,"

Phrase: "Jack P."
Processing 00000000.tx.3: Goodman Jr., Luiz Juliano, and Louis B. 

Phrase: "Goodman Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Luiz Juliano,"

Phrase: "and"

Phrase: "Louis B."
Processing 00000000.tx.4: Hersh From the Department of Biochemistry, University of Kentucky, Lexington, Kentucky 40536-0084,Mass Spectrometry Facility, University of Kentucky, Lexington, Kentucky 40506-0286,and the Department of Biophysics, Escola Paulista de Medicina, Sao Paulo 04034,Brazil Received for publication, September 22,2000  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES Recombinant rat insulysin was shown to cleave the internally quenched fluorogenic peptide 2-aminobenzyl-GGFLRKVGQ-ethylenediamine-2,4-dinitrophenol at the R-K bond, exhibiting a Km of 13M and a Vmax of 2.6mol min1 mg1. 

Phrase: "Hersh From the Department of Biochemistry,"

Phrase: "University of Kentucky,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Lexington,"

Phrase: "Kentucky 40536-0084,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022557:Kentucky [Geographic Area]

Phrase: "Mass Spectrometry Facility,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547538:Facility [Idea or Concept]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]

Phrase: "University of Kentucky,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Lexington,"

Phrase: "Kentucky 40506-0286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022557:Kentucky [Geographic Area]

Phrase: "and"

Phrase: "the Department of Biophysics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Escola Paulista de Medicina,"

Phrase: "Sao Paulo 04034,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1862323:SAO [Gene or Genome]

Phrase: "Brazil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006137:Brazil [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "September 22,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Recombinant rat insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULYSIN [Gene or Genome]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "the internally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205102:Internally [Spatial Concept]

Phrase: "quenched"

Phrase: "fluorogenic peptide 2-aminobenzyl-GGFLRKVGQ-ethylenediamine-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
   795   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "4-dinitrophenol at the R-K bond,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "a Km of 13M"

Phrase: "and"

Phrase: "a Vmax of 2.6mol min1 mg1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710637:Vmax [Phenomenon or Process]
Processing 00000000.tx.5: Derivatives of this peptide in which the P2 leucine or the P2' valine were replaced with other residues were used to probe the subsite specificity of the enzyme. 

Phrase: "Derivatives of this peptide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0243072:derivatives [Chemical Viewed Structurally]
   737 E C1527240:Derivative [Functional Concept]

Phrase: "in which"

Phrase: "the P2 leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "the P2' valine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "replaced with other residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "the subsite specificity of the enzyme."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0678612:enzyme specificity [Natural Phenomenon or Process]
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.6: Varying the P2 residue produced a 4-fold range in Km and a 7-fold range in kcat. 

Phrase: "Varying"

Phrase: "the P2 residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "produced"

Phrase: "a 4-fold range in Km"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "a 7-fold range in kcat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]
Processing 00000000.tx.7: The nature of the P2 residue had a significant effect on the site of cleavage. 

Phrase: "The nature of the P2 residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]

Phrase: "had"

Phrase: "a significant effect on the site of cleavage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.8: Leucine, isoleucine, valine, and aspartate produced cleavage at the R-K bond. 

Phrase: "Leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "isoleucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "valine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "produced"

Phrase: "cleavage at the R-K bond."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
Processing 00000000.tx.9: Asparagine produced 36% cleavage at the N-R bond and 64% cleavage at the R-K bond, whereas with alanine or serine the A-R and S-R bonds were the major cleavage sites. 

Phrase: "Asparagine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003995:Asparagine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "produced"

Phrase: "36% cleavage at the N-R bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "64% cleavage at the R-K bond,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "whereas with alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "the A-R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and S-"

Phrase: "R bonds"

Phrase: "were"

Phrase: "the major cleavage sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.10: With tyrosine, phenylalanine, methionine, or histidine representing the varied residue X, cleavages at F-X, X-R, and R-K were seen, whereas with tryptophan equal cleavage occurred at the F-W and W-R bonds. 

Phrase: "With tyrosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phenylalanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "methionine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "histidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the varied residue X,"

Phrase: "cleavages at F-X,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0010813:cleavage [Cell Function]
   737   C0596311:Cleavage [Phenomenon or Process]
   737   C1330957:cleavage [Cell Function]

Phrase: "X-R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "R-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "were"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: ","

Phrase: "whereas with tryptophan equal cleavage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0010813:cleavage [Cell Function]
   760   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205163:Equal [Qualitative Concept]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
   760   C1549782:Equal [Idea or Concept]

Phrase: "occurred at the F-W"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   760   C0439133:(f) [Intellectual Product]
   760   C1553038:[f] [Quantitative Concept]
   760   C1709305:Occurred [Activity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "W-R bonds."
Processing 00000000.tx.11: Variable P2' residues produce less of a change in both Km and kcat and have little influence on the cleavage site. 

Phrase: "Variable P2' residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "produce"

Phrase: "less of a change"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392747:Change [Functional Concept]
   770   C0439092:less [Intellectual Product]
   770   C0443172:change [Quantitative Concept]
   770   C0547044:Less [Qualitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in both Km"

Phrase: "and"

Phrase: "kcat"

Phrase: "and"

Phrase: "have"

Phrase: "little influence on the cleavage site."
Processing 00000000.tx.12: Exceptions are phenylalanine, tyrosine, leucine, and isoleucine, which in addition to producing cleavage at the R-K bond, produce significant cleavage at the L-R bond. 

Phrase: "Exceptions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1554961:exception [Idea or Concept]
   966   C1705847:Exception [Conceptual Entity]

Phrase: "are"

Phrase: "phenylalanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "tyrosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "isoleucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "which in addition to producing cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
   753   C1883712:Addition [Functional Concept]

Phrase: "at the R-K bond,"

Phrase: "produce"

Phrase: "significant cleavage at the L-R bond."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
Processing 00000000.tx.13: Alanine and tyrosine were unique in producing cleavage at the F-L bond. 

Phrase: "Alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "unique in producing cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710548:Unique [Qualitative Concept]

Phrase: "at the F-L bond."
Processing 00000000.tx.14: Taken together, these data suggest that insulysin specificity is directed toward the amino side of hydrophobic and basic residues and that the enzyme has an extended substrate binding site.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulysin specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "is"

Phrase: "directed toward the amino side of hydrophobic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441987:Side [Spatial Concept]
   748   C0598629:Hydrophobic [Qualitative Concept]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "basic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "an extended substrate binding site."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C1710236:Substrate [Manufactured Object]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES Insulysin (insulin-degrading enzyme; EC 3.4.24.56) was first described as a proteolytic enzyme capable of degrading insulin (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "(insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "; EC 3.4.24.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "described as a proteolytic enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0030940:Proteolytic enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1947941:Proteolytic Enzyme [Enzyme]
           proteolytic
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0597304:Proteolytic [Molecular Function]
   760   C1552738:described [Idea or Concept]

Phrase: "capable of degrading insulin"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: The enzyme is primarily located in the cytosol and peroxisomes (2), although its presence on the cell membrane (3, 4) and its secretion (5) have recently been reported. 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "primarily"

Phrase: "located in the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "its presence on the cell membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")"

Phrase: "and"

Phrase: "its secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.17: Although insulysin has the highest affinity for insulin, the enzyme has been shown to cleave a number of other physiological peptides in vitro including glucagon (6), insulin-like growth factors I and II (7), atrial natriuretic peptide (8), and transforming growth factor- (9). 

Phrase: "Although"

Phrase: "insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "has"

Phrase: "the highest affinity for insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "a number of other physiological peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "insulin-like growth factors I"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   983   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   983   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   823   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   771   C0037657:Insulin-Like Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   737 E C1753359:insulin-like growth factor [Molecular Function]

Phrase: "and"

Phrase: "II"

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.18: The finding of a variety of substrates for the enzyme, as well as its presence at high levels in insulin-insensitive cells, suggest that insulysin has a variety of physiological functions. 

Phrase: "The finding of a variety of substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "for the enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "as well as"

Phrase: "its presence at high levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in insulin-insensitive cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "has"

Phrase: "a variety of physiological functions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]
Processing 00000000.tx.19: Those proposed include processing of insulin for antigen recognition (10), regulation of the multicatalytic proteinase (11), and modulation of steroid receptor action (12). 

Phrase: "Those proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "processing of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1158354:insulin processing [Molecular Function]
   790   C1709694:Processing [Activity]

Phrase: "for antigen recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678894:antigen recognition [Organ or Tissue Function]
   861   C0524637:Recognition [Mental Process]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "regulation of the multicatalytic proteinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "modulation of steroid receptor action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.20: Insulysin was shown to be identical to an enzymatic activity referred to as -endorphin-generating enzyme, an enzyme that converts -endorphin to -endorphin (endorphin 1-17) and endorphin 1-18 (13). 

Phrase: "Insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identical to an enzymatic activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as -endorphin-generating enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "an enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "that converts -endorphin to -endorphin"

Phrase: "(endorphin 1-17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0205752:endorphin [Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "endorphin 1-18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0205752:endorphin [Biologically Active Substance]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.21: In that study GRF, dynorphin B 1-13, dynorphin A 1-17, and pancreastatin 1-49 were shown also to be substrates. 

Phrase: "In"

Phrase: "that study GRF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023610:GRF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C1706512:GRF [Gene or Genome]

Phrase: "dynorphin B 1-13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0073381:Dynorphin B [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   812   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418447:dynorphin [Gene or Genome]

Phrase: "dynorphin A 1-17,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0086191:DYNORPHIN A 1 17 [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           Dynorphin (1-17)
           Dynorphin A
   812   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418447:dynorphin [Gene or Genome]

Phrase: "and"

Phrase: "pancreastatin 1-49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0070009:pancreastatin [Amino Acid, Peptide, or Protein]
   827   C1332754:pancreastatin [Gene or Genome]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "also to"

Phrase: "be"

Phrase: "substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.22: Recent interest in insulysin stems from its ability to degrade the amyloid peptides A 140 and A 1-42 (5, 14-16) and its possible role as an enzyme involved in the clearance of amyloid peptides in the brain. 

Phrase: "Recent interest in insulysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "stems from its ability to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0085732:Ability [Organism Attribute]
   760   C0242767:Stem [Plant]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "degrade"

Phrase: "the amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A 140"

Phrase: "and"

Phrase: "A 1-42"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "14-16"

Phrase: ")"

Phrase: "and"

Phrase: "its possible role as an enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "involved in the clearance of amyloid peptides"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0449297:Clearance [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1314939:Involved [Functional Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.23: Decreases in insulysin activity in the brains of Alzheimer's patients have been suggested to contribute to the progression of this disease (17). 

Phrase: "Decreases in insulysin activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0547047:decreases [Quantitative Concept]
   737 E C0392756:Decrease [Qualitative Concept]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of Alzheimer's patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the progression of this disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0242656:Disease Progression [Pathologic Function]
           progression
   774   C1947900:Disease progression NOS [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0449258:Progression [Functional Concept]
   748   C1880177:Contribute [Activity]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.24: Insulysin is a 110-kDa zinc metallopeptidase member of the invercinzin family of proteases, characterized by an inverted active site motif, HXXEH, relative to the more common HEXXH motif. 

Phrase: "Insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "is"

Phrase: "a 110-kDa zinc metallopeptidase member of the invercinzin family of proteases,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0086282:Family member [Family Group]
   751   C1611821:Family Member [Intellectual Product]
   736   C0680022:member [Population Group]
   736   C2698041:Member [Professional or Occupational Group]

Phrase: "characterized by an inverted active site motif,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0205681:Active Site [Functional Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205177:Active [Functional Concept]
   748   C0443241:Inverted [Qualitative Concept]
   748   C1514562:Motif [Amino Acid Sequence]
   748   C1515974:Site [Body Location or Region]
   748   C1880022:Characterized [Activity]
   748   C2825164:Site [Spatial Concept]

Phrase: "HXXEH,"

Phrase: "relative to the more common HEXXH motif."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.25: The two histidines in this motif are ligands for the active site zinc atom, and the glutamate serves either as a nucleophile attacking the susceptible peptide bond or more likely as a general acid catalyst facilitating the attack of a water molecule on the scissile bond (18). 

Phrase: "The two histidines in this motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "are"

Phrase: "ligands for the active site zinc atom,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023688:Ligands [Chemical]

Phrase: "and"

Phrase: "the glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "serves"

Phrase: "either as a nucleophile attacking"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1261512:attacking [Social Behavior]
   726 E C0277793:Attack, NOS [Temporal Concept]
   726 E C1304680:Attack [Finding]

Phrase: "the susceptible peptide bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0678595:peptide bond [Natural Phenomenon or Process]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "more likely as a general acid catalyst"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0001128:Acid [Chemical]
   748   C0175921:Catalyst [Phenomenon or Process]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0205172:More [Functional Concept]
   748   C0205246:General [Spatial Concept]
   748   C0332148:Likely [Qualitative Concept]
   748   C0750492:Likely [Idea or Concept]
   748   C1553889:General [Idea or Concept]

Phrase: "facilitating"

Phrase: "the attack of a water molecule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0277793:Attack, NOS [Temporal Concept]
   753   C1261512:attack [Social Behavior]
   753   C1304680:Attack [Finding]

Phrase: "on the scissile bond"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.26: The functionality of these three residues has been established by site-directed mutagenesis (18-20). 

Phrase: "The functionality of these three residues"

Phrase: "has"

Phrase: "been"

Phrase: "established by site-directed mutagenesis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   760   C0079866:Mutagenesis [Molecular Function]
   760   C0205145:Site [Spatial Concept]
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   760   C3146302:Mutagenesis [Laboratory Procedure]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "(18-20"

Phrase: ")."
Processing 00000000.tx.27: The specificity of insulysin toward peptide bond cleavage is complex and not fully understood. 

Phrase: "The specificity of insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "toward peptide bond cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   734   C0678595:peptide bond [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.28: Authier et al. 

Phrase: "Authier et al."
Processing 00000000.tx.29: (6) examined the cleavage sites in a variety of peptides and concluded that the enzyme exhibited a preference for basic (arginine) or large hydrophobic (phenylalanine, leucine, tyrosine) amino acids to occupy the carboxyl (P1) side of the cleavage site. 

Phrase: "(6"

Phrase: ")"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the cleavage sites in a variety of peptides"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   750   C2945843:Site of [Qualitative Concept]
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a preference for basic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0558295:preference [Idea or Concept]
   770   C1549513:Preference [Idea or Concept]

Phrase: "(arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "large hydrophobic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598629:Hydrophobic [Qualitative Concept]

Phrase: "(phenylalanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "amino acids to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "occupy"

Phrase: "the carboxyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596260:Carboxyl [Organic Chemical]

Phrase: "(P1) side of the cleavage site."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441987:Side [Spatial Concept]
Processing 00000000.tx.30: We previously conducted a similar analysis of the substrate specificity of the enzyme and also concluded that the enzyme exhibits a preference, but not absolute specificity, for cleavage at hydrophobic and basic residues (13). 

Phrase: "We previously"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "a similar analysis of the substrate specificity of the enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "also"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a preference,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0558295:preference [Idea or Concept]
  1000   C1549513:Preference [Idea or Concept]

Phrase: "but"

Phrase: "not absolute specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "for cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "at hydrophobic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobic [Qualitative Concept]

Phrase: "and"

Phrase: "basic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.31: However, we suggested that the specificity of insulysin is directed at the amino side (P1') rather than the carboxyl side (P1) of the bond cleaved. 

Phrase: "However,"

Phrase: "we"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the specificity of insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "is"

Phrase: "directed at the amino side"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441987:Side [Spatial Concept]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "(P1')"

Phrase: "rather than"

Phrase: "the carboxyl side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "(P1) of the bond"

Phrase: "cleaved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]
Processing 00000000.tx.32: It has also been proposed that the specificity of the enzyme is governed by the three-dimensional structure of the substrate (2). 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "the specificity of the enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0678612:enzyme specificity [Natural Phenomenon or Process]
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "is"

Phrase: "governed by the three-dimensional structure of the substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0450363:3-Dimensional [Spatial Concept]
   742   C0205449:Three [Quantitative Concept]
   742   C0678594:Structure [Spatial Concept]
   742   C1710236:Substrate [Manufactured Object]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.33: This is not inconsistent with the specificity being directed at basic and hydrophobic residues, because it has been observed that substrates bind in an extended -like structure to many proteases. 

Phrase: "This"

Phrase: "is"

Phrase: "not inconsistent with the specificity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442809:Inconsistent [Qualitative Concept]

Phrase: "being"

Phrase: "directed at basic"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1527178:Basic [Functional Concept]
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]
   718 E C0920750:basicity [Quantitative Concept]

Phrase: "and"

Phrase: "hydrophobic residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "because"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "bind in an extended -"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "like structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "to many proteases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]
Processing 00000000.tx.34: In this study we have introduced the use of internally quenched fluorogenic peptides as substrates for insulysin. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "the use of internally"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "quenched"

Phrase: "fluorogenic peptides as substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "for insulysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]
Processing 00000000.tx.35: We have used these peptides to further probe the specificity of the enzyme. 

Phrase: "We"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these peptides to further"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "the specificity of the enzyme."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0678612:enzyme specificity [Natural Phenomenon or Process]
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.36: The results indicate the importance of subsite interactions in determining cleavage sites and further support the suggestion that insulysin specificity is directed at the amino side of hydrophobic and basic residues.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "the importance of subsite interactions"

Phrase: "in determining cleavage sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the suggestion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038659:Suggestion [Idea or Concept]
  1000   C1705535:suggestion [Idea or Concept]

Phrase: "that insulysin specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "is"

Phrase: "directed at the amino side of hydrophobic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441987:Side [Spatial Concept]
   748   C0598629:Hydrophobic [Qualitative Concept]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "basic residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.37: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES Expression and Purification of Recombinant Insulysin-- A rat insulysin cDNA (3), kindly provided by Dr. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Purification of Recombinant Insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243114:purification [Functional Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "A rat insulysin cDNA (3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C1415875:INSULYSIN [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.38: Richard Roth of Stanford University, was subcloned into the pFASTBAC vector (Life Technologies, Inc.) using BamHI and XhoI restriction sites such that a His6 affinity tag became fused to the N terminus of the protein. 

Phrase: "Richard Roth of Stanford University,"

Phrase: "was"

Phrase: "subcloned into the pFASTBAC vector"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BamHI"

Phrase: "and"

Phrase: "XhoI restriction sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "such"

Phrase: "that"

Phrase: "a His6 affinity tag"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1505208:his6 tag [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: "became"

Phrase: "fused to the N terminus of the protein."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0699952:Fused [Functional Concept]
   711 E C1414861:FUSE [Gene or Genome]
   711 E C1708111:Fuse [Manufactured Object]
Processing 00000000.tx.39: The insulysin portion of the fusion protein started at methionine 42,which corresponds to the second putative start site in the coding region. 

Phrase: "The insulysin portion of the fusion protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "started at methionine 42,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1272689:Started [Qualitative Concept]
   737 E C0439659:Start [Temporal Concept]

Phrase: "which"

Phrase: "corresponds to the second putative start site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0205145:Site [Spatial Concept]
   748   C0205436:Second [Quantitative Concept]
   748   C0439659:Start [Temporal Concept]
   748   C0457385:Second [Temporal Concept]
   748   C0565930:/second [Quantitative Concept]
   748   C1515974:Site [Body Location or Region]
   748   C1561503:second [Idea or Concept]
   748   C1705190:Second [Qualitative Concept]
   748   C2825164:Site [Spatial Concept]
   738   C0175668:Secondary to [Temporal Concept]

Phrase: "in the coding region."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.40: This latter site is believed to be the one utilized in vivo (21). 

Phrase: "This latter site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "utilized"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.41: Generation of recombinant baculovirus and expression of recombinant insulysin in Sf9 cells were done according to the manufacturer's instructions. 

Phrase: "Generation of recombinant baculovirus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "expression of recombinant insulysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Sf9 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C3494245:Sf9 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "done according to the manufacturer's instructions."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1272695:Done [Qualitative Concept]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C2746065:Done [Temporal Concept]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.42: For the purification of recombinant insulysin, a 1:10 (w/v) suspension of Sf9 cells expressing the enzyme was prepared in 100mM potassium phosphate buffer, pH 7.3,containing 1mM dithiothreitol (K-PO4/dithioerythritol buffer). 

Phrase: "For the purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "of recombinant insulysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULYSIN [Gene or Genome]

Phrase: "a 1"

Phrase: ":"

Phrase: "10"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "suspension of Sf9 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0038960:Suspension [Biomedical or Dental Material]
   770   C1382107:Suspension [Substance]
   770   C1705537:Suspension [Functional Concept]

Phrase: "expressing"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "prepared in 100mM potassium phosphate buffer,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   790   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0032821:Potassium [Element, Ion, or Isotope]
   753   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   719   C1521827:Prepare [Functional Concept]

Phrase: "pH 7.3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "(K-PO4/dithioerythritol buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.43: The cells were sonicated using a Branson sonifier (setting 3at 30%) 10times, each time for 1s. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "sonicated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Branson sonifier"

Phrase: "("

Phrase: "setting"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0542559:setting [Functional Concept]
  1000   C1318139:{Setting} [Quantitative Concept]
   966 E C0036849:Set [Mental Process]
   966 E C1442518:Set [Functional Concept]
   966 E C1705195:Set [Conceptual Entity]

Phrase: "3at 30%"

Phrase: ")"

Phrase: "10times,"

Phrase: "each time for 1s."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.44: The sonicate was centrifuged at 75,000g for 20min to pellet the membrane fraction, and the supernatant containing insulysin was loaded onto a 5-ml nickel-nitrilotriacetic acid column (Qiagen) that had been equilibrated with the K-PO4/dithioerythritol buffer. 

Phrase: "The sonicate"

Phrase: "was"

Phrase: "centrifuged at 75,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 20min"

Phrase: "to pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "the membrane fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "the supernatant containing insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULYSIN [Gene or Genome]

Phrase: "was"

Phrase: "loaded onto a 5-ml nickel-nitrilotriacetic acid column"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0256984:nickel nitrilotriacetic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   764   C0028132:Nitrilotriacetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0001128:Acid [Chemical]
   742   C0028013:nickel [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0439526:/mL [Quantitative Concept]
   742   C1185738:Column [Body Part, Organ, or Organ Component]
   742   C1706132:Column [Idea or Concept]
   742   C1708715:Loaded [Activity]
   742   C2348274:Nickel [Element, Ion, or Isotope]
   708 E C1550025:Load [Idea or Concept]
   708 E C1704782:Load [Manufactured Object]

Phrase: "(Qiagen"

Phrase: ")"

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "equilibrated with the K-PO4/dithioerythritol buffer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0012786:Dithioerythreitol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.45: After extensive washing of the column with starting buffer and then with 20mM imidazole buffer, pH 7.3,the enzyme was eluted with 500mM imidazole buffer, pH 7.3.

Phrase: "After extensive washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Washing [Activity]

Phrase: "of the column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "with starting buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "then with 20mM imidazole buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   760   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]
   760   C1883708:Then [Temporal Concept]

Phrase: "pH 7.3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "eluted with 500mM imidazole buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   760   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.46: From a 100-ml culture ~2 mg of purified enzyme was obtained. 

Phrase: "From a 100-ml culture ~2 mg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0439294:ml mg [Quantitative Concept]
   804   C0439269:mg% [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "of purified enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.47: The purified enzyme was essentially homogeneous as judged by SDS-polyacrylamide gel electrophoresis (Fig. 1). 

Phrase: "The purified enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "essentially homogeneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881065:Homogeneous [Qualitative Concept]

Phrase: "as"

Phrase: "judged by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   719   C0221191:Judge [Professional or Occupational Group]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.48: View larger version (37K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.49: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.50: SDS-polyacrylamide gel electrophoresis analysis of purified rat insulysin. 

Phrase: "SDS-polyacrylamide gel electrophoresis analysis of purified rat insulysin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
Processing 00000000.tx.51: Insulysin (15g) purified by affinity chromatography as described under "Materials and Methods" was analyzed by SDS-polyacrylamide gel electrophoresis on a 7.5% gel stained with Coomassie Blue. 

Phrase: "Insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "(15g"

Phrase: ")"

Phrase: "purified by affinity chromatography"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008551:Chromatography, Affinity [Laboratory Procedure]
   770   C0008550:Chromatography [Laboratory Procedure]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C1998793:Purified [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "analyzed by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0936012:Analyzed [Research Activity]
   753   C1382104:Gel [Substance]

Phrase: "on a 7.5% gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: "stained with Coomassie Blue."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.52: HPLC1 Assays-- During purification, the activity of insulysin was assayed by measuring the disappearance of -endorphin using reverse phase HPLC as described previously (13), except that isocratic elution was employed. 

Phrase: "HPLC1 Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "During purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "the activity of insulysin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed by measuring"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756   C0005507:Assay [Laboratory Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "the disappearance of -endorphin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0205752:endorphin [Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "reverse phase HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that isocratic elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1441565:Elution [Laboratory Procedure]

Phrase: "was"

Phrase: "employed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.53: A 100-l reaction mixture containing 40mM potassium phosphate buffer, pH 7.3,30M -endorphin, and enzyme was incubated for 15min at 37C. 

Phrase: "A 100-l reaction mixture containing 40mM potassium phosphate buffer,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   807   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   807   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   791   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   791   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   791   C0031701:phosphate [Organophosphorus Compound]
   791   C0032821:Potassium [Element, Ion, or Isotope]
   791   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   791   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "30M -endorphin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0205752:endorphin [Biologically Active Substance]

Phrase: "and"

Phrase: "enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "incubated for 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.54: The reaction was stopped by the addition of 10l of 5.5% trifluoroacetic acid, producing a final concentration of 0.5%. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of 10l of 5.5% trifluoroacetic acid,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   756   C0040982:Trifluoroacetic Acid [Organic Chemical]
   738   C0001128:Acid [Chemical]
   738   C0202406:Acid [Laboratory Procedure]
   738   C1272691:stopped [Qualitative Concept]
   738   C1883712:Addition [Functional Concept]
   704 E C1947925:Stop [Activity]
   704 E C2746065:Stop [Temporal Concept]

Phrase: "producing"

Phrase: "a final concentration of 0.5%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.55: The reaction mixture was loaded onto a C4 reverse phase HPLC column (Vydac, Hisperia, CA) and separated isocratically at 32% acetonitrile in 0.1% aqueous trifluoroacetic acid. 

Phrase: "The reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "loaded onto a C4 reverse phase HPLC column"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0008562:HPLC [Laboratory Procedure]
   744   C0205390:Phase [Temporal Concept]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1555029:Reverse [Idea or Concept]
   744   C1706132:Column [Idea or Concept]
   744   C1708715:Loaded [Activity]
   711 E C1550025:Load [Idea or Concept]
   711 E C1704782:Load [Manufactured Object]

Phrase: "(Vydac,"

Phrase: "Hisperia,"

Phrase: "CA)"

Phrase: "and"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "isocratically at 32% acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0050456:acetonitrile [Organic Chemical]

Phrase: "in 0.1% aqueous trifluoroacetic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0040982:Trifluoroacetic Acid [Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.56: The endorphin, which eluted at ~8 min, was detected by absorbance at 214nm using a Waters detector and quantitated from its peak area. 

Phrase: "The endorphin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C0205752:endorphin [Biologically Active Substance]

Phrase: "which"

Phrase: "eluted"

Phrase: "at ~8 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "detected by absorbance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442726:Detected [Finding]
   790   C1268822:Absorbance [Clinical Attribute]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 214nm"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Waters detector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0180392:Detector [Medical Device]
   861   C1705235:Detector [Manufactured Object]

Phrase: "and"

Phrase: "quantitated from its peak area."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]
   760   C0444505:Peak [Quantitative Concept]
Processing 00000000.tx.57: Fluorogenic Assays and Determination of Kinetic Parameters-- The reaction of fluorogenic substrates containing an N-terminal 2-aminobenzyl (Abz) group and a C-terminal ethylenediamine-2,4-dinitrophenyl group (EDDnp) was measured by the increase in fluorescence that occurs upon cleavage of any peptide bond and the separation of the quenching EDDnp group from the fluorescent Abz group. 

Phrase: "Fluorogenic Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "Determination of Kinetic Parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "The reaction of fluorogenic substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an N-terminal 2-aminobenzyl (Abz) group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "a C-terminal ethylenediamine-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C1825406:A-2 [Gene or Genome]
   840   C1707271:C-Terminal [Amino Acid Sequence]
   804   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
   804   C0205088:Terminal [Temporal Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]

Phrase: "4-dinitrophenyl group (EDDnp)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "measured by the increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0442805:Increase [Functional Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "in fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "that"

Phrase: "occurs upon cleavage of any peptide bond"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0678595:peptide bond [Natural Phenomenon or Process]
   748   C0010813:cleavage [Cell Function]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "the separation of the quenching EDDnp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0036679:Separation [Pathologic Function]
   748   C0237868:Separation [Social Behavior]
   748   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "EDDnp group from the fluorescent Abz group."
Processing 00000000.tx.58: Peptides were synthesized and purified by HPLC as described previously (22) and prepared as 1mM stock solutions in 20% dimethylformamide. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "purified by HPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C1998793:Purified [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "prepared as 1mM stock solutions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0037633:Solutions [Substance]
   760   C1710198:Stock [Idea or Concept]
   726 E C0525069:Solution [Biomedical or Dental Material]
   726   C1521827:Prepare [Functional Concept]

Phrase: "in 20% dimethylformamide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012426:Dimethylformamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.59: The peptide concentration was calculated from the absorbance at 357nm (=10mM). 

Phrase: "The peptide concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "calculated from the absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444686:Calculated [Functional Concept]
   770   C1268822:Absorbance [Clinical Attribute]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 357nm"

Phrase: "("

Phrase: "=10mM"

Phrase: ")."
Processing 00000000.tx.60: Reaction mixtures contained the fluorogenic peptide substrate, insulysin, and 20mM potassium phosphate buffer, pH 7.3.

Phrase: "Reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the fluorogenic peptide substrate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0016349:Fluorogenic Substrate [Indicator, Reagent, or Diagnostic Aid]
   827   C1710236:Substrate [Manufactured Object]

Phrase: "insulysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "and"

Phrase: "20mM potassium phosphate buffer,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0032821:Potassium [Element, Ion, or Isotope]
   812   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.61: The reaction was initiated by the addition of enzyme and monitored continuously on a Hitachi model F2000 spectrofluorometer equipped with a chart recorder. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "initiated by the addition of enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C1883712:Addition [Functional Concept]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "continuously on a Hitachi model F2000 spectrofluorometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "equipped with a chart recorder."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0182914:Chart recorder [Medical Device]
   760   C0007963:chart [Medical Device]
   760   C0182913:Recorder [Medical Device]
   760   C0684240:chart [Intellectual Product]
   760   C1705115:Recorder [Medical Device]
Processing 00000000.tx.62: Excitation and emission wavelengths were 318and 418nm, respectively. 

Phrase: "Excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "emission wavelengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449819:wavelengths [Quantitative Concept]

Phrase: "were"

Phrase: "318and 418nm,"

Phrase: "respectively."
Processing 00000000.tx.63: The relationship between fluorescence change and peptide concentration was determined by measuring the total fluorescence change that occurred upon complete hydrolysis of the peptide with trypsin (22). 

Phrase: "The relationship between fluorescence change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "peptide concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the total fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "occurred upon complete hydrolysis of the peptide"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0020291:Hydrolysis [Natural Phenomenon or Process]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0205197:Complete [Qualitative Concept]
   748   C0725685:COMPLEAT [Food]
   748   C1709305:Occurred [Activity]
   714 E C2745955:OCCUR [Temporal Concept]

Phrase: "with trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.64: Kinetic data were fit to computer programs of Cleland (23). 

Phrase: "Kinetic data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "fit to computer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036572:Fit [Sign or Symptom]
   790   C0424576:Fit [Finding]
   790   C2349186:Fit [Activity]

Phrase: "programs of Cleland"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0376691:Programs [Intellectual Product]
   790   C1709697:Program [Conceptual Entity]
   790   C2728259:Program [Pharmacologic Substance]
   790   C3484370:Program [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.65: Determination of Sites of Peptide Cleavage-- Reaction mixtures containing 40M fluorogenic peptide were allowed to react for varying time periods and stopped as noted above. 

Phrase: "Determination of Sites of Peptide Cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "--"

Phrase: "Reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "40M fluorogenic peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "react for varying time periods"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0439582:Time periods [Temporal Concept]
   778 E C0585019:Temporal periods [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   726   C0439531:/period [Temporal Concept]
   726   C1948053:Period [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "stopped as noted above."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.66: The reaction mixture was then subjected to HPLC using a gradient of 5% acetonitrile in 0.1% aqueous trifluoroacetic acid to 50% acetonitrile in 0.1% aqueous trifluoroacetic acid. 

Phrase: "The reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to HPLC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0008562:HPLC [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a gradient of 5% acetonitrile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]

Phrase: "in 0.1% aqueous trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0040982:Trifluoroacetic Acid [Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "to 50% acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050456:acetonitrile [Organic Chemical]

Phrase: "in 0.1% aqueous trifluoroacetic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0040982:Trifluoroacetic Acid [Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.67: Product peaks were either collected and identified by matrix-assisted laser desorption ionization time of flight mass spectrometry or by comparison of the retention times of products to those of previously identified peptides. 

Phrase: "Product peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "either"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "identified by matrix-assisted laser desorption ionization time of flight mass spectrometry"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
   938   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   841   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   770   C2348791:Time-of-Flight [Quantitative Concept]
   753   C0037813:Mass Spectrometry [Laboratory Procedure]
   751   C0596822:laser spectrometry [Laboratory Procedure]
   736   C0023089:Laser [Manufactured Object]
   736   C0040223:Time [Temporal Concept]
   736   C0205396:Identified [Qualitative Concept]
   736   C0436196:Spectrometry [Laboratory Procedure]
   736   C0458142:Laser [Phenomenon or Process]
   736   C0577559:Mass [Finding]
   736   C0596801:Ionization [Phenomenon or Process]
   736   C1023865:Laser [Plant]
   736   C1269765:Assisted [Finding]
   736   C1306372:*Mass [Quantitative Concept]
   736   C1550043:Identified [Finding]
   736   C1551388:Identified [Functional Concept]
   736   C1555977:Flight [Intellectual Product]
   736   C1704640:Matrix [Spatial Concept]
   736   C1706315:Laser [Medical Device]
   736   C1706515:Matrix [Body Substance]
   736   C2610507:flight [Phenomenon or Process]
   736   C3152252:Mass [Quantitative Concept]
   736   C3541383:Time [Temporal Concept]
   703 E C0018896:assist [Social Behavior]
   703 E C0557034:assist [Health Care Activity]

Phrase: "or by comparison of the retention times of products"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   742   C0035280:Retention [Mental Process]
   742   C0040223:times [Temporal Concept]
   742   C0333117:Retention [Functional Concept]
   742   C1514468:Products [Entity]
   742   C1632851:Times [Quantitative Concept]
   742   C1707455:Comparison [Activity]
   742   C1753315:retention [Cell Function]
   708 E C1704444:Product [Quantitative Concept]
   708 E C3541383:Time [Temporal Concept]

Phrase: "to those"

Phrase: "of previously identified peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.68: In some cases product identification was verified by mixing a known product with the unknown and demonstrating co-chromatography in the HPLC gradient system.  

Phrase: "In some cases product identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020792:Identification [Mental Process]
   827   C0205396:Identification [Qualitative Concept]

Phrase: "was"

Phrase: "verified by mixing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205430:mixing [Functional Concept]
   790   C1711411:Verified [Functional Concept]
   756 E C1421951:MIX [Gene or Genome]
   756 E C1720722:Mix [Qualitative Concept]

Phrase: "a known product with the unknown"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "demonstrating"

Phrase: "co-chromatography in the HPLC gradient system."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0008550:Chromatography [Laboratory Procedure]
Processing 00000000.tx.69: RESULTS AND DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES Insulysin activity has generally been assayed with iodinated insulin as substrate. 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulysin activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "generally"

Phrase: "been"

Phrase: "assayed with iodinated insulin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "as substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.70: This assay involves reaction of the enzyme with this substrate, followed by precipitation of unreacted insulin with trichloroacetic acid and subsequent measurement of the radiolabeled products in the supernatant. 

Phrase: "This assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "involves"

Phrase: "reaction of the enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]

Phrase: "with this substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "followed by precipitation of unreacted insulin"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0032931:Precipitation [Natural Phenomenon or Process]
   753   C0032932:Precipitation [Molecular Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1642401:% precipitation [Quantitative Concept]
   753   C2584299:Precipitation [Natural Phenomenon or Process]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "with trichloroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "subsequent measurement of the radiolabeled products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:Measurement [Functional Concept]

Phrase: "in the supernatant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.71: Although this assay is rather sensitive, it has several disadvantages. 

Phrase: "Although"

Phrase: "this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "rather sensitive,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "it"

Phrase: "has"

Phrase: "several disadvantages."
Processing 00000000.tx.72: It is cumbersome, the products formed are not determined during the reaction, it requires several cleavages of the insulin molecule to release soluble products, it is a discontinuous assay, and it requires handling radioactive material. 

Phrase: "It"

Phrase: "is"

Phrase: "cumbersome,"

Phrase: "the products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "determined during the reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]

Phrase: "it"

Phrase: "requires"

Phrase: "several cleavages of the insulin molecule to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0010813:cleavage [Cell Function]
   714   C0596311:Cleavage [Phenomenon or Process]
   714   C1330957:cleavage [Cell Function]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "soluble products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "a discontinuous assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "it"

Phrase: "requires"

Phrase: "handling radioactive material."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]
Processing 00000000.tx.73: An alternative assay was developed (13) in which the disappearance of another insulysin substrate, -endorphin, is measured by HPLC. 

Phrase: "An alternative assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "developed"

Phrase: "(13"

Phrase: ")"

Phrase: "in which"

Phrase: "the disappearance of another insulysin substrate, -"

Phrase: "endorphin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C0205752:endorphin [Biologically Active Substance]

Phrase: "is"

Phrase: "measured by HPLC."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.74: This assay has the advantage that it does not require a radioactive substrate, but it has the disadvantages that it is also a discontinuous assay, it follows substrate disappearance rather than product appearance, and it requires ~1 h for each HPLC run. 

Phrase: "This assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "has"

Phrase: "the advantage"

Phrase: "that"

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "a radioactive substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "but"

Phrase: "it"

Phrase: "has"

Phrase: "the disadvantages"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "a discontinuous assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "it"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "substrate disappearance"

Phrase: "rather than"

Phrase: "product appearance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233426:Appearance [Organism Attribute]
   861   C0700364:Appearance [Qualitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "requires"

Phrase: "~1 h for each HPLC run."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0700308:1 H [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.75: In this study the use of an isocratic system rather than a gradient system to follow -endorphin disappearance reduced the assay time from over an hour to less than 10min. 

Phrase: "In this"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the use of an isocratic system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "rather than"

Phrase: "a gradient system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "follow -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "endorphin disappearance"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the assay time from over"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "an hour to less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439227:Hour [Temporal Concept]
   770   C0564385:/hour [Quantitative Concept]

Phrase: "than 10min."
Processing 00000000.tx.76: In an attempt to develop a simpler continuous assay for the enzyme, we tested as a substrate the internally quenched fluorogenic peptide Abz-GGFLRKVGQ-EDDnp, which contains a central core of both hydrophobic and basic residues, which are cleavage sites in the substrates -endorphin and insulin. 

Phrase: "In an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "develop"

Phrase: "a simpler continuous assay for the enzyme,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "tested as a substrate"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0392366:tested [Intellectual Product]
   770   C1710236:Substrate [Manufactured Object]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "the internally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205102:Internally [Spatial Concept]

Phrase: "quenched"

Phrase: "fluorogenic peptide Abz-GGFLRKVGQ-EDDnp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "EDDnp,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a central core of both hydrophobic"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0333763:central core [Cell Component]
   753   C0444669:Core [Spatial Concept]
   753   C1167518:core [Cell Component]
   753   C1706352:Core [Medical Device]
   753   C1882467:Core [Manufactured Object]
   753   C3274653:Core [Body Substance]

Phrase: "and"

Phrase: "basic residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "cleavage sites in the substrates -endorphin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.77: Cleavage of any peptide bond in this substrate produces an increase in fluorescence as the quenching of the N-terminal fluorescent Abz group by the C-terminal EDDnp group is relieved (24, 25). 

Phrase: "Cleavage of any peptide bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "in this substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "produces"

Phrase: "an increase in fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "as the quenching"

Phrase: "of the N-terminal fluorescent Abz group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]

Phrase: "by the C-terminal EDDnp"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
   812   C0205088:Terminal [Temporal Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]

Phrase: "EDDnp group"

Phrase: "is"

Phrase: "relieved"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1301771:Relieved [Qualitative Concept]
   966 E C1301676:relieve [Functional Concept]
   907 E C0332303:relieving [Functional Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.78: We found this peptide to be cleaved by purified recombinant insulysin, yielding a Km of 21M and a Vmax of ~0.2 mol min1 mg1 of enzyme. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "this peptide to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "be"

Phrase: "cleaved by purified recombinant insulysin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C1415875:INSULYSIN [Gene or Genome]
   760   C1514798:recombinant [Organism]
   760   C1998793:Purified [Functional Concept]

Phrase: "yielding"

Phrase: "a Km of 21M"

Phrase: "and"

Phrase: "a Vmax of ~0.2 mol min1 mg1 of enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1417498:MG1 [Gene or Genome]
Processing 00000000.tx.79: This can be compared with -endorphin, which exhibits a Km of 13M and a Vmax of 2.6mol min1 mg1. 

Phrase: "This"

Phrase: "can"

Phrase: "be"

Phrase: "compared with -endorphin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0205752:endorphin [Biologically Active Substance]
   790   C1707455:Compared [Activity]

Phrase: "which"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a Km of 13M"

Phrase: "and"

Phrase: "a Vmax of 2.6mol min1 mg1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710637:Vmax [Phenomenon or Process]
Processing 00000000.tx.80: Cleavage of Abz-GGFLRKVGQ-EDDnp occurred at a single site, the R-K bond (Fig. 2). 

Phrase: "Cleavage of Abz-GGFLRKVGQ-EDDnp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "EDDnp"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "occurred at a single site,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205145:Site [Spatial Concept]
   760   C0205171:Single [Quantitative Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1709305:Occurred [Activity]
   760   C2825164:Site [Spatial Concept]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "the R-K bond"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.81: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.82: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.83: HPLC chromatograms showing the hydrolysis products generated from internally quenched peptides. 

Phrase: "HPLC chromatograms"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the hydrolysis products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "generated from internally quenched peptides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C0205102:Internally [Spatial Concept]
   760   C3146294:Generated [Activity]
Processing 00000000.tx.84: Reaction mixtures containing 40M internally quenched peptides were reacted with rat insulysin in 50mM potassium phosphate buffer, pH 7.3.

Phrase: "Reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "40M internally quenched peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "reacted with rat insulysin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1415875:INSULYSIN [Gene or Genome]

Phrase: "in 50mM potassium phosphate buffer,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0032821:Potassium [Element, Ion, or Isotope]
   812   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.85: Reaction products were separated by gradient HPLC on a Vydac C4 reverse phase column as described under "Materials and Methods." 

Phrase: "Reaction products"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by gradient HPLC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0008562:HPLC [Laboratory Procedure]
   770   C0086972:Separated [Finding]
   770   C0439182:% gradient [Quantitative Concept]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C0812409:Gradient [Quantitative Concept]

Phrase: "on a Vydac C4 reverse phase column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.86: Product peaks were collected and identified by either comparison to standards or by mass spectrometry. 

Phrase: "Product peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "identified by either comparison"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1707455:Comparison [Activity]

Phrase: "to standards"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038137:standards [Intellectual Product]
  1000   C0175675:Standards [Qualitative Concept]
   966 E C1442989:Standard [Qualitative Concept]
   966 E C2828392:Standard [Intellectual Product]

Phrase: "or by mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.87: Shown are the products derived from Abz-GGFXRKVGQ-EDDnp where X=leucine (A), X=tryptophan (B), and X=phenylalanine (C). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "derived from Abz-GGFXRKVGQ-EDDnp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "EDDnp where X=leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "X=tryptophan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "X=phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.88: The major peak eluting between 35and 40min represents unreacted substrate. 

Phrase: "The major peak eluting between 35and 40min"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "unreacted substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.89: The ability to use quenched fluorogenic peptides as substrates for insulysin permitted an assessment of the effect of varying the amino acid residue at specific positions on the hydrolysis of peptides by this enzyme. 

Phrase: "The ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "quenched fluorogenic peptides as substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "for insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "permitted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0329040:permitted [Fish]
   966 E C0023636:Permit [Regulation or Law]

Phrase: "an assessment of the effect of varying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1261322:Assessment [Health Care Activity]
   748   C1516048:Assessment [Activity]

Phrase: "the amino acid residue at specific positions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "on the hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "of peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "by this enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.90: Shown in Table I is the effect of varying amino acids in the P2 position.2 It can be seen that variable P2 residues affect the apparent kcat, with a 7-fold variation in this parameter observed, whereas Km varies less than 4-fold; 

Phrase: "Shown in Table I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "the effect of varying amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in the P2 position.2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0733755:Position [Spatial Concept]
   827   C1384585:P2 [Immunologic Factor]
   827   C1419693:P2 [Gene or Genome]
   827   C1539372:p2 [Gene or Genome]
   755 E C0240795:POSITIONAL [Finding]

Phrase: "It"

Phrase: "can"

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "that variable P2 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the apparent kcat,"

Phrase: "with a 7-fold variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variation [Qualitative Concept]

Phrase: "in this parameter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0549193:Parameter [Spatial Concept]
  1000   C1704769:Parameter [Conceptual Entity]
  1000   C2350001:Parameter [Quantitative Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "whereas"

Phrase: "Km"

Phrase: "varies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548673:Varies [Intellectual Product]

Phrase: "less than 4-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0439092:Less Than [Intellectual Product]
           less
   770   C0332462:Fold [Spatial Concept]
   770   C0547044:Less [Qualitative Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.91: and changes in kcat/Km more or less parallel kcat. 

Phrase: "and"

Phrase: "changes in kcat/Km more"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "parallel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "kcat."
Processing 00000000.tx.92: As shown in Table I and exemplified in Fig. 

Phrase: "As"

Phrase: "shown in Table I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "exemplified in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.93: 2, there is a rather profound effect of the P2 residue on the site of bond cleavage. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "there"

Phrase: "is"

Phrase: "a rather profound effect of the P2 residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "of bond cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
Processing 00000000.tx.94: With the aliphatic residues leucine, isoleucine, valine, and aspartate, cleavage occurs exclusively at the R-K bond. 

Phrase: "With the aliphatic residues leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "isoleucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "valine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "aspartate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "exclusively at the R-K bond."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205090:R- [Spatial Concept]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0684010:R. [Professional or Occupational Group]
   753   C1708601:K' [Quantitative Concept]
   753   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.95: With asparagine, cleavage at the N-R bond is observed about one third of the time, whereas with the small side chains of alanine and serine, the major cleavage sites are the A-R and S-R bonds, respectively. 

Phrase: "With asparagine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003995:Asparagine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cleavage at the N-R bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "observed about one third of the time,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C3241998:one time [Intellectual Product]
   748   C0040223:Time [Temporal Concept]
   748   C0205437:Third [Quantitative Concept]
   748   C0205447:One [Quantitative Concept]
   748   C1441672:Observed [Functional Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "whereas with the small side chains of alanine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0337112:chains [Manufactured Object]
   744   C0441987:Side [Spatial Concept]
   744   C0700321:Small [Quantitative Concept]
   744   C1524075:Chains [Idea or Concept]

Phrase: "and"

Phrase: "serine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "the major cleavage sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "the A-R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and S-"

Phrase: "R bonds,"

Phrase: "respectively."
Processing 00000000.tx.96: With tyrosine, phenylalanine, methionine, or histidine corresponding to the variable amino acid, three cleavage sites are observed, which are at the F-X bond, the X-R bond, and the R-K bond. 

Phrase: "With tyrosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phenylalanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "methionine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "histidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "corresponding to the variable amino acid,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0439828:Variable [Qualitative Concept]

Phrase: "three cleavage sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "are at the F-X bond,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C1551058:Are [Quantitative Concept]
   753   C1553038:[f] [Quantitative Concept]

Phrase: "the X-R bond,"

Phrase: "and"

Phrase: "the R-K bond."
Processing 00000000.tx.97: The extent of cleavage at each of these sites is dependent on the particular amino acid residue present. 

Phrase: "The extent of cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "at each"

Phrase: "of these sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "dependent on the particular amino acid residue present."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
Processing 00000000.tx.98: With tryptophan, cleavage at the R-K bond does not occur; 

Phrase: "With tryptophan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "cleavage at the R-K bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.99: however, cleavage is seen at the F-W and W-R bonds at about equal frequency. 

Phrase: "however,"

Phrase: "cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "seen at the F-W"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   760   C0205397:Seen [Qualitative Concept]
   760   C0439133:(f) [Intellectual Product]
   760   C1553038:[f] [Quantitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "and"

Phrase: "W-R bonds at about equal frequency."
Processing 00000000.tx.100: It should be noted that product analysis revealed only the intact N- and C-terminal fragments resulting from the indicated cleavage sites. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that product analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the intact N-"

Phrase: "and"

Phrase: "C-terminal fragments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "resulting from the indicated cleavage sites."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   753   C0010813:cleavage [Cell Function]
   753   C0205145:Sites [Spatial Concept]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C0678226:resulting [Functional Concept]
   753   C1330957:cleavage [Cell Function]
   753   C1444656:Indicated [Finding]
   719 E C1274040:Result [Functional Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]
   719 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.101: No fragments corresponding to secondary cleavages were observed.  

Phrase: "No fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "corresponding to secondary cleavages"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0175668:Secondary to [Temporal Concept]
           Secondary
   770   C0027627:secondary [Neoplastic Process]
   770   C0205436:Secondary [Quantitative Concept]
   737   C0010813:cleavage [Cell Function]
   737   C0596311:Cleavage [Phenomenon or Process]
   737   C1330957:cleavage [Cell Function]

Phrase: "were"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.102: View this table: [in this window] [in a new window]  Table I Effect of variable P2 residues on the kinetics of hydrolysis of the peptide series Abz-GGFXRKVGQ-EDDnp by rat insulysin at pH 7.3 Kinetic constants are reported along with their standard errors. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Effect of variable P2 residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022702:Kinetics [Natural Phenomenon or Process]
  1000   C0220865:kinetics [Functional Concept]
  1000   C2825046:Kinetics [Occupation or Discipline]

Phrase: "of hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "of the peptide series Abz-GGFXRKVGQ-EDDnp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   799   C0205549:Series [Quantitative Concept]
   799   C2348044:Series [Intellectual Product]

Phrase: "EDDnp by rat insulysin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0441876:Group 4 [Intellectual Product]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "at pH 7.3 Kinetic constants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1547014:*Constant [Quantitative Concept]
   771   C1948059:Constant [Qualitative Concept]

Phrase: "are"

Phrase: "reported along with their standard errors."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   756   C1710181:Standard Error [Quantitative Concept]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C0743559:errors [Qualitative Concept]
   753   C1442989:Standard [Qualitative Concept]
   753   C2828392:Standard [Intellectual Product]
   753   C3496591:Reported [Clinical Attribute]
   719 E C1608199:Error [Functional Concept]
   719 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.103: These data indicate that there are multiple alignments permitted for substrate binding. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that there"

Phrase: "are"

Phrase: "multiple alignments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706765:Alignment [Quantitative Concept]

Phrase: "permitted for substrate binding."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0243122:binding [Functional Concept]
   770   C0329040:permitted [Fish]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1710236:Substrate [Manufactured Object]
   737 E C0023636:Permit [Regulation or Law]
Processing 00000000.tx.104: Subsite interactions between the enzyme and the substrate govern these alignments, which in turn determine which bond is cleaved. 

Phrase: "Subsite interactions between the enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C1373066:Enzyme Interactions [Molecular Function]
   781 E C3537101:Enzyme Interaction [Molecular Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "govern"

Phrase: "these alignments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706765:Alignment [Quantitative Concept]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "determine"

Phrase: "which"

Phrase: "bond"

Phrase: "is"

Phrase: "cleaved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]
Processing 00000000.tx.105: Within the sequences tested, the bulky hydrophobic amino acids leucine, isoleucine, and valine, as well as aspartate, appear to be accommodated only as a P2 residue leading to cleavage exclusively at the R-K bond. 

Phrase: "Within the sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "the bulky hydrophobic amino acids leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "isoleucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "and"

Phrase: "valine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "aspartate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "accommodated"

Phrase: "only as a P2 residue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205171:Only [Quantitative Concept]
   760   C1384585:P2 [Immunologic Factor]
   760   C1419693:P2 [Gene or Genome]
   760   C1539372:p2 [Gene or Genome]
   760   C1709915:Residue [Conceptual Entity]
   760   C1720467:Only [Intellectual Product]
   760   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "leading to cleavage exclusively"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0010813:cleavage [Cell Function]
   770   C0332152:Leading [Temporal Concept]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "at the R-K bond."
Processing 00000000.tx.106: Leucine produces the highest kcat value when acting as a P2 residue (Table II). 

Phrase: "Leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "produces"

Phrase: "the highest kcat value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522609:Value [Quantitative Concept]

Phrase: "when"

Phrase: "acting as a P2 residue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1384585:P2 [Immunologic Factor]
   760   C1419693:P2 [Gene or Genome]
   760   C1539372:p2 [Gene or Genome]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   726   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "(Table II"

Phrase: ")."
Processing 00000000.tx.107: At the other extreme, tryptophan does not appear to occupy the P2 position. 

Phrase: "At the"

Phrase: "other extreme, tryptophan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occupy"

Phrase: "the P2 position."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.108: Two nonexclusive explanations that can account for this observation are possible. 

Phrase: "Two nonexclusive explanations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681841:Explanations [Intellectual Product]

Phrase: "that"

Phrase: "can"

Phrase: "account for this observation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1551359:account [Idea or Concept]
   770   C1964257:Observation [Diagnostic Procedure]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "are"

Phrase: "possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.109: Tryptophan may fit poorly into the S2 subsite of the enzyme. 

Phrase: "Tryptophan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "may"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "poorly into the S2 subsite of the enzyme."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0205169:Poorly [Qualitative Concept]
   744   C1179705:S2 [Body Location or Region]
   744   C1419032:S2 [Gene or Genome]
   744   C1419718:S2 [Gene or Genome]
   744   C1710234:Subsite [Spatial Concept]
Processing 00000000.tx.110: Additionally, tryptophan may be favored as both a P1 and P1' residue and thus within the sequence FWRKV cleavages at F-W or W-R occur much faster than at the R-K bond. 

Phrase: "Additionally,"

Phrase: "tryptophan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "favored as both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "a P1"

Phrase: "and"

Phrase: "P1' residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "thus within the sequence FWRKV cleavages"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]
   719   C0010813:cleavage [Cell Function]
   719   C0596311:Cleavage [Phenomenon or Process]
   719   C1330957:cleavage [Cell Function]

Phrase: "at F-W"

Phrase: "or"

Phrase: "W-R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "much faster than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0015663:Fast [Finding]
   756   C0456962:Fast [Qualitative Concept]

Phrase: "at the R-K bond."
Processing 00000000.tx.111: All other residues examined appear to be capable of occupying the P2 position but have a relatively small influence on the rate of cleavage at the R-K bond (Table II). 

Phrase: "All"

Phrase: "other residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "capable of occupying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "the P2 position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "but"

Phrase: "have"

Phrase: "a relatively small influence on the rate of cleavage"

Phrase: "at the R-K bond"

Phrase: "(Table II"

Phrase: ")."
Processing 00000000.tx.112: This suggests that there is no correlation between cleavage at a particular bond and kcat.  

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "no correlation between cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "at a particular bond"

Phrase: "and"

Phrase: "kcat."
Processing 00000000.tx.113: View this table: [in this window] [in a new window]  Table II Effect of variable P1 residues on the kcat for specific cleavages The kcat values for cleavage at specific sites were calculated from the data in Table I. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II Effect of variable P1 residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the kcat"

Phrase: "for specific cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "The kcat values for cleavage"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "at specific sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0449604:Specific site [Spatial Concept]
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "calculated from the data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "in Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.114: As shown in Tables I and II, within the sequence FXRKV, where X is the variable amino acid, only a limited number of residues were found to serve as P1' residues. 

Phrase: "As"

Phrase: "shown in Tables I"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:tables [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706074:Tables [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
   737 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "II,"

Phrase: "within the sequence FXRKV,"

Phrase: "where X"

Phrase: "is"

Phrase: "the variable amino acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a limited number of residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "serve as P1' residues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.115: These were the aromatic amino acids and methionine. 

Phrase: "These"

Phrase: "were"

Phrase: "the aromatic amino acids"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0301713:Amino Acids, Aromatic [Amino Acid, Peptide, or Protein]
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   827   C0772162:Aromatic [Organic Chemical,Pharmacologic Substance]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "methionine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.116: Of these, tyrosine produces the highest kcat for cleavage at the F-X bond. 

Phrase: "Of these,"

Phrase: "tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "produces"

Phrase: "the highest kcat for cleavage"

Phrase: "at the F-X bond."
Processing 00000000.tx.117: Within this varied sequence, the enzyme accepts a variety of amino acids as P1 residues, with the rate of cleavage exhibiting an ~10-fold variation dependent on the specific residue occupying this position. 

Phrase: "Within this varied sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "accepts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272684:accept [Qualitative Concept]
  1000   C1548601:Accept [Idea or Concept]

Phrase: "a variety of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "as P1 residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "with the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "an ~10-fold variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variation [Qualitative Concept]

Phrase: "dependent on the specific residue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "occupying"

Phrase: "this position."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.118: Leucine, valine, isoleucine, and aspartate, although not found as P1 residues, were found as P2 residues. 

Phrase: "Leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "valine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "isoleucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "and"

Phrase: "aspartate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found as P1 residues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "were"

Phrase: "found as P2 residues."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0150312:Found [Quantitative Concept]
   770   C1384585:P2 [Immunologic Factor]
   770   C1419693:P2 [Gene or Genome]
   770   C1539372:p2 [Gene or Genome]
   737 E C0243095:Find [Finding]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.119: The variety of amino acid types that can occupy the P1 position and the observation that insulysin appears to favor cleavage at hydrophobic and basic residues (6, 13) make it less likely that insulysin specificity is directed at the P1 residue. 

Phrase: "The variety of amino acid types"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "that"

Phrase: "can"

Phrase: "occupy"

Phrase: "the P1 position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "cleavage at hydrophobic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "basic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(6,"

Phrase: "13"

Phrase: ")"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it less likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332148:Likely [Qualitative Concept]
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that insulysin specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "is"

Phrase: "directed at the P1 residue."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.120: The effect of varying the P2' residue is shown in Table III. 

Phrase: "The effect of varying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the P2' residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "is"

Phrase: "shown in Table III."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C0439070:III [Intellectual Product]
   770   C1705160:III [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.121: With the exception of aspartate, which is the least favored residue in the P2' position, there is less than a 5-fold effect of variable P2' residues on the apparent kcat, whereas Km varies only ~3-fold. 

Phrase: "With the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of aspartate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "the least favored residue in the P2' position,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1709915:Residue [Conceptual Entity]
   744   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "there"

Phrase: "is"

Phrase: "less than a 5-fold effect of variable P2' residues"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0439092:Less Than [Intellectual Product]
           less
   739   C0332462:Fold [Spatial Concept]
   739   C0439828:Variable [Qualitative Concept]
   739   C0547044:Less [Qualitative Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C1384585:P2 [Immunologic Factor]
   739   C1419693:P2 [Gene or Genome]
   739   C1539372:p2 [Gene or Genome]
   739   C1880834:FOLD [Phenomenon or Process]
   739   C2348382:Effect [Qualitative Concept]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "on the apparent kcat,"

Phrase: "whereas"

Phrase: "Km"

Phrase: "varies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548673:Varies [Intellectual Product]

Phrase: "only ~3-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.122: When one considers the rates for cleavage specifically at the R-K bond, excluding aspartate, an ~8-fold range of kcat values becomes evident. 

Phrase: "When"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "considers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "the rates for cleavage specifically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "at the R-K bond,"

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "aspartate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an ~8-fold range of kcat values"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1547411:Value range [Idea or Concept]
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C3542016:Range [Intellectual Product]

Phrase: "becomes"

Phrase: "evident."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.123: Histidine and serine are the preferred residues at this site, with no obvious pattern of discrimination among other types of side chains. 

Phrase: "Histidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "are"

Phrase: "the preferred residues at this site,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "with no obvious pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "of discrimination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012632:Discrimination [Mental Process]
  1000   C2987623:Discrimination [Social Behavior]

Phrase: "among other types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332307:Types [Qualitative Concept]
   966 E C1547052:*Type [Quantitative Concept]

Phrase: "of side chains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337112:chains [Manufactured Object]
   861   C0441987:Side [Spatial Concept]
   861   C1524075:Chains [Idea or Concept]
Processing 00000000.tx.124: There is also an effect of the P2' residue on the site of cleavage. 

Phrase: "There"

Phrase: "is"

Phrase: "also"

Phrase: "an effect of the P2' residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "of cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]
Processing 00000000.tx.125: The aromatic amino acids phenylalanine and tyrosine and the hydrophobic amino acids leucine and isoleucine produce significant cleavage at the L-R bond and thus act as P3' residues. 

Phrase: "The aromatic amino acids phenylalanine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C0301713:Amino Acids, Aromatic [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "the hydrophobic amino acids leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "isoleucine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "produce"

Phrase: "significant cleavage at the L-R bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "thus"

Phrase: "act as P3' residues."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C1412751:P3 [Gene or Genome]
   770   C1427831:P3 [Gene or Genome]
   770   C1539372:p3 [Gene or Genome]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.126: Alanine, but not serine, and to a lesser extent tyrosine produce cleavage at the F-L bond, placing these residues in the P4' position. 

Phrase: "Alanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "not serine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and to a lesser extent tyrosine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0439792:Extent [Spatial Concept]
   753   C0547044:Lesser [Qualitative Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "produce"

Phrase: "cleavage at the F-L bond,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "placing"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442504:placing [Spatial Concept]
   966 E C1704765:Place [Functional Concept]
   966 E C1882509:Place [Activity]
   966 E C3496241:place [Disease or Syndrome]

Phrase: "these residues in the P4' position."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.127: These data indicate that insulysin contains an extended active site, with residues in the S2', S3', and S4' subsites contributing to specificity.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an extended active site,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0205681:Active Site [Functional Concept]
   827   C0205145:Site [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "with residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "in the S2',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: "S3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179706:S3 [Body Location or Region]
  1000   C1335643:S3 [Gene or Genome]
  1000   C1419033:S3 [Gene or Genome]

Phrase: "and"

Phrase: "S4' subsites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710234:Subsite [Spatial Concept]

Phrase: "contributing to specificity."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0037791:Specificity [Quantitative Concept]
   790   C1511884:Specificity [Quantitative Concept]
   790   C1880177:Contributing [Activity]
   718 E C0205369:Specific [Qualitative Concept]
   718 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.128: View this table: [in this window] [in a new window]  Table III Effect of variable P2' residues on the kinetics of hydrolysis of the peptide series Abz-GGFLRKXGQ-EDDnp by rat insulysin at pH 7.3 Kinetic constants are reported along with their standard errors. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table III Effect of variable P2' residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022702:Kinetics [Natural Phenomenon or Process]
  1000   C0220865:kinetics [Functional Concept]
  1000   C2825046:Kinetics [Occupation or Discipline]

Phrase: "of hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "of the peptide series Abz-GGFLRKXGQ-EDDnp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   799   C0205549:Series [Quantitative Concept]
   799   C2348044:Series [Intellectual Product]

Phrase: "EDDnp by rat insulysin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0441876:Group 4 [Intellectual Product]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "at pH 7.3 Kinetic constants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1547014:*Constant [Quantitative Concept]
   771   C1948059:Constant [Qualitative Concept]

Phrase: "are"

Phrase: "reported along with their standard errors."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   756   C1710181:Standard Error [Quantitative Concept]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C0743559:errors [Qualitative Concept]
   753   C1442989:Standard [Qualitative Concept]
   753   C2828392:Standard [Intellectual Product]
   753   C3496591:Reported [Clinical Attribute]
   719 E C1608199:Error [Functional Concept]
   719 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.129: The effects seen by P2' residues differ from those seen with P2 residues because none of the P2' residues serve as cleavage sites. 

Phrase: "The effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "seen by P2' residues"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205397:Seen [Qualitative Concept]
   770   C1384585:P2 [Immunologic Factor]
   770   C1419693:P2 [Gene or Genome]
   770   C1539372:p2 [Gene or Genome]
   737 E C0042789:see [Organism Function]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
   737 E C1947903:See [Activity]

Phrase: "differ from those"

Phrase: "seen with P2 residues"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205397:Seen [Qualitative Concept]
   770   C1384585:P2 [Immunologic Factor]
   770   C1419693:P2 [Gene or Genome]
   770   C1539372:p2 [Gene or Genome]
   737 E C0042789:see [Organism Function]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
   737 E C1947903:See [Activity]

Phrase: "because"

Phrase: "none of the P2' residues"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   760   C1384585:P2 [Immunologic Factor]
   760   C1419693:P2 [Gene or Genome]
   760   C1539372:p2 [Gene or Genome]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "serve as cleavage sites."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0010813:cleavage [Cell Function]
   770   C0205145:Sites [Spatial Concept]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.130: However, these residues can influence the cleavage site. 

Phrase: "However,"

Phrase: "these residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "can"

Phrase: "influence"

Phrase: "the cleavage site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.131: There are a number of possible explanations for this, the simplest being that lysine is a poor P1 residue. 

Phrase: "There"

Phrase: "are"

Phrase: "a number of possible explanations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "for this,"

Phrase: "the simplest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205352:Simple [Qualitative Concept]

Phrase: "being"

Phrase: "that lysine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "a poor P1 residue."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.132: The rate enhancements produced by P2' residues on cleavage at the R-K bond probably result from increased binding energy produced through distal subsite interactions. 

Phrase: "The rate enhancements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   827   C2349975:Enhancement [Activity]

Phrase: "produced by P2' residues"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1384585:P2 [Immunologic Factor]
   770   C1419693:P2 [Gene or Genome]
   770   C1539372:p2 [Gene or Genome]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "on cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "at the R-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "bond"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "result from increased binding energy"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   797   C0455769:Increased energy [Finding]
   760   C0205217:Increased [Quantitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C0424589:Energy [Finding]
   760   C0442805:Increased [Functional Concept]
   760   C0542479:Energy [Natural Phenomenon or Process]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1274040:Result [Functional Concept]
   760   C1442080:Energy [Quantitative Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "produced through distal subsite interactions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205108:Distal [Spatial Concept]
   760   C1710234:Subsite [Spatial Concept]
   726   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.133: Those residues that produce additional cleavage sites probably destabilize interactions at the S2 subsite and/or produce favorable interactions at the S3 subsite. 

Phrase: "Those residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "produce"

Phrase: "additional cleavage sites probably"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "destabilize"

Phrase: "interactions at the S2 subsite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and/or"

Phrase: "produce"

Phrase: "favorable interactions at the S3 subsite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.134: The data in Tables II and III also provide insight into the rate-determining step of the reaction. 

Phrase: "The data in Tables II"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1706074:Data Table [Intellectual Product]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "III also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight into the rate-determining step of the reaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0233820:Insight [Mental Process]
Processing 00000000.tx.135: Because the insulysin reaction involves the conversion of a single substrate into two products, there are three potential rate-determining steps. 

Phrase: "Because"

Phrase: "the insulysin reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "involves"

Phrase: "the conversion of a single substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439836:Conversion [Functional Concept]

Phrase: "into two products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "there"

Phrase: "are"

Phrase: "three potential rate-determining steps."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0871208:Rate [Activity]
   804   C1261552:steps [Conceptual Entity]
   804   C1521828:Rate [Quantitative Concept]
   771 E C1704379:Step [Functional Concept]
   771 E C1705117:Step [Quantitative Concept]
   771 E C2825408:Step [Manufactured Object]
Processing 00000000.tx.136: These are the release of the N-terminal fragment of the substrate, the release of the C-terminal fragment of the substrate, or cleavage of the peptide bond. 

Phrase: "These"

Phrase: "are"

Phrase: "the release of the N-terminal fragment of the substrate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0030685:Release [Health Care Activity]
   739   C0391871:Release [Functional Concept]
   739   C0439180:% release [Quantitative Concept]
   739   C0680255:release [Health Care Activity]
   739   C1283071:Release [Functional Concept]
   739   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the release of the C-terminal fragment of the substrate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0030685:Release [Health Care Activity]
   739   C0391871:Release [Functional Concept]
   739   C0439180:% release [Quantitative Concept]
   739   C0680255:release [Health Care Activity]
   739   C1283071:Release [Functional Concept]
   739   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "cleavage of the peptide bond."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
Processing 00000000.tx.137: As seen in Table II, with Abz-GGFXRKVGQ-EDDnp as substrate, variable amino acids in the N-terminal portion of the substrate produce a greater than 7-fold variation in kcat when one considers formation of the common C-terminal product RKVGQ-EDDnp. 

Phrase: "As"

Phrase: "seen in Table II,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0205397:Seen [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "with Abz-GGFXRKVGQ-EDDnp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]

Phrase: "EDDnp as substrate,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0441876:Group 4 [Intellectual Product]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "variable amino acids in the N-terminal portion of the substrate"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   773   C1706793:N-Terminal Amino Acid [Amino Acid Sequence]
   756   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0001128:Acids [Chemical]
   722 E C2917660:Amino Acid [Pharmacologic Substance]
   704 E C0202406:Acid [Laboratory Procedure]

Phrase: "produce"

Phrase: "a greater than 7-fold variation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439093:Greater Than [Quantitative Concept]
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]

Phrase: "in kcat"

Phrase: "when"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "considers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "formation of the common C-terminal product RKVGQ-EDDnp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "EDDnp."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
Processing 00000000.tx.138: Similarly, a 14-fold variation for formation of the common C-terminal product KVGQ-EDDnp is seen. 

Phrase: "Similarly,"

Phrase: "a 14-fold variation for formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "of the common C-terminal product KVGQ-EDDnp"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C1707271:C-Terminal [Amino Acid Sequence]
   795   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
   795   C0205088:Terminal [Temporal Concept]
   795   C0205214:Common [Quantitative Concept]
   795   C1514468:product [Entity]
   795   C1522138:Common [Functional Concept]
   795   C1704444:Product [Quantitative Concept]
   795   C1705314:Terminal [Manufactured Object]
   795   C1705315:Terminal [Spatial Concept]
   795   C3245511:common [Intellectual Product]

Phrase: "EDDnp"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "seen."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]
Processing 00000000.tx.139: If release of these C-terminal fragments were rate-limiting, these products would all exhibit the same kcat. 

Phrase: "If"

Phrase: "release of these C-terminal fragments"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "rate-limiting,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0439801:limiting [Functional Concept]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]
   827 E C1549649:Limit [Idea or Concept]
   827 E C2349209:Limit [Conceptual Entity]

Phrase: "these products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "would"

Phrase: "all"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "the same kcat."
Processing 00000000.tx.140: Similarly, the data in Table III show a greater than 9-fold variation for release of the common N-terminal product Abz-GGFLR when the amino acid in the C-terminal part of the substrate is varied. 

Phrase: "Similarly,"

Phrase: "the data in Table III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1706074:Data Table [Intellectual Product]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a greater than 9-fold variation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439093:Greater Than [Quantitative Concept]
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]

Phrase: "for release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of the common N-terminal product Abz-GGFLR"

Phrase: "when"

Phrase: "the amino acid in the C-terminal part of the substrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1707271:C-Terminal Amino Acid [Amino Acid Sequence]
   756   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C2917660:Amino Acid [Pharmacologic Substance]
   738   C0001128:Acid [Chemical]
   738   C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "varied."
Processing 00000000.tx.141: These data indicate that release of the N-terminal fragment is also not the rate-limiting step. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that release of the N-terminal fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the rate-limiting step."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]
Processing 00000000.tx.142: One is left to conclude that the cleavage of the peptide bond is the rate-limiting step of the reaction, at least with the peptides used in this study. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the cleavage of the peptide bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "the rate-limiting step of the reaction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1261552:Step [Conceptual Entity]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "with the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.143: Together, the data support our previous proposal (13) that insulysin prefers to cleave at hydrophobic (preferably aromatic hydrophobic) residues and basic residues. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our previous proposal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555306:proposal [Idea or Concept]
   861   C1948033:Proposal [Intellectual Product]

Phrase: "(13"

Phrase: ")"

Phrase: "that insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "prefers"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave at hydrophobic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0598629:Hydrophobic [Qualitative Concept]

Phrase: "(preferably aromatic hydrophobic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598629:Hydrophobic [Qualitative Concept]

Phrase: ")"

Phrase: "residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "basic residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.144: The data further suggest that the specificity of insulysin is directed toward the amino side of these residues. 

Phrase: "The data further"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the specificity of insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "is"

Phrase: "directed toward the amino side of these residues."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0441987:Side [Spatial Concept]
   711   C0439851:Direct [Qualitative Concept]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]
   711   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.145: Multiple subsite interactions are possible, permitting different alignments of the substrate relative to the catalytic site. 

Phrase: "Multiple subsite interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "possible,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "permitting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0023636:Permit [Regulation or Law]
   966   C0329040:Permit [Fish]

Phrase: "different alignments of the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1706765:Alignment [Quantitative Concept]

Phrase: "relative to the catalytic site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.146: These interactions determine the site of bond cleavage and to a lesser extent the rate of bond cleavage. 

Phrase: "These interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "determine"

Phrase: "the site of bond cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "and to a lesser extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "the rate of bond cleavage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.147: Together these factors provide insights into the complex cleavage pattern observed when insulysin acts on physiological substrates.  

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insights into the complex cleavage pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:insights [Mental Process]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "acts on physiological substrates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0205463:Physiological [Functional Concept]
   737   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.148: ACKNOWLEDGEMENT We thank Dr. 

Phrase: "ACKNOWLEDGEMENT"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.149: Richard Roth of Stanford University for providing us with the cDNA clone to rat insulysin.  

Phrase: "Richard Roth of Stanford University"

Phrase: "for providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "us with the cDNA clone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0009013:Clone [Cell]
   760   C1522642:Clone [Tissue]

Phrase: "to rat insulysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULYSIN [Gene or Genome]
Processing 00000000.tx.150: FOOTNOTES * This work was supported in part by National Institute on Drug Abuse Grants DA02243 and DA 07062.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institute on Drug Abuse Grants DA02243"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   747   C1513899:National Institute on Drug Abuse [Health Care Related Organization]

Phrase: "and"

Phrase: "DA 07062."
Processing 00000000.tx.151: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.152: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.153: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.154: To whom correspondence should be addressed: Dept. of Biochemistry, College of Medicine, Chandler Medical Center, University of Kentucky, 800Rose St., Lexington, KY40536-0084. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0557806:College [Manufactured Object]

Phrase: "Chandler Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "University of Kentucky,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "800Rose St., Lexington,"

Phrase: "KY40536-0084."
Processing 00000000.tx.155: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.156: 859-323-5549; 

Phrase: "859-323-5549"

Phrase: ";"
Processing 00000000.tx.157: Fax: 859-323-1727; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "859-323-1727"

Phrase: ";"
Processing 00000000.tx.158: E-mail: lhersh@pop.uky.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "lhersh@pop.uky.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.159: Published, JBC Papers in Press, October 19,2000,DOI 10.1074/jbc.M008702200 2 The nomenclature of Schechter and Berger (26) is used in which the residue on the carboxyl side of the bond being cleaved is designated as the P1 residue, and the residue on the amino side of the bond being cleaved is designated as the P1' residue. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "October 19,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M008702200 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2348291:DOI [Classification]

Phrase: "The nomenclature of Schechter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600281:Nomenclature [Intellectual Product]
   770   C1524067:Nomenclature [Intellectual Product]

Phrase: "and"

Phrase: "Berger"

Phrase: "(26"

Phrase: ")"

Phrase: "is"

Phrase: "used in which"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "the residue on the carboxyl side of the bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1709915:Residue [Conceptual Entity]
   742   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "being"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "is"

Phrase: "designated as the P1 residue,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1524084:Designated [Functional Concept]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "the residue on the amino side of the bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1709915:Residue [Conceptual Entity]
   742   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "being"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "is"

Phrase: "designated as the P1' residue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1524084:Designated [Functional Concept]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.160: Subsequent residues are designated P2', P3', P2, P3, etc. 

Phrase: "Subsequent residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "P2',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "P3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "P2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "P3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "etc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]
Processing 00000000.tx.161: With the fluorogenic peptides used in this study, a number of them are cleaved at multiple positions. 

Phrase: "With the fluorogenic peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "used in this study,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "a number of them"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "cleaved at multiple positions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]
   770   C0439064:Multiple [Quantitative Concept]
   770   C0733755:positions [Spatial Concept]
Processing 00000000.tx.162: For simplicity and based on the parent peptide Abz-GGFLRKVGQ-EDDnp, which is cleaved at the R-K bond, we refer to the R residue as the P1 residue and the K residue as the P1' residue.  

Phrase: "For simplicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205352:Simple [Qualitative Concept]

Phrase: "and"

Phrase: "based on the parent peptide Abz-GGFLRKVGQ-EDDnp"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   742   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
   742   C0030551:parent [Family Group]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   742   C2699423:Parent [Conceptual Entity]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "EDDnp,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "which"

Phrase: "is"

Phrase: "cleaved at the R-K bond,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205090:R- [Spatial Concept]
   753   C0205242:Cleaved [Spatial Concept]
   753   C0333853:Cleaved [Cell]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0684010:R. [Professional or Occupational Group]
   753   C1708601:K' [Quantitative Concept]
   753   C2603358:R' [Clinical Attribute]

Phrase: "we"

Phrase: "refer to the R residue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205090:R- [Spatial Concept]
   760   C0205543:refer [Functional Concept]
   760   C0684010:R. [Professional or Occupational Group]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   760   C2603358:R' [Clinical Attribute]

Phrase: "as the P1 residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "the K residue as the P1' residue."
Processing 00000000.tx.163: ABBREVIATIONS The abbreviations used are: HPLC, high performance liquid chromatography; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high performance liquid chromatography"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
  1000   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
  1000   C1579831:High performance liquid chromatography [Functional Concept]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0597198:Performance [Individual Behavior]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C1882330:Performance [Activity]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.164: Abz, 2-aminobenzyl; 

Phrase: "Abz, 2-aminobenzyl"

Phrase: ";"
Processing 00000000.tx.165: EDDnp, ethylenediamine-2,4-dinitrophenyl.  

Phrase: "EDDnp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]

Phrase: "EDDnp,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "ethylenediamine-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]

Phrase: "4-dinitrophenyl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.166: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.167: Mirsky, I. 

Phrase: "Mirsky,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.168: A., and Broh-Kahn, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Broh-Kahn,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.169: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.170: (1949) Arch. 

Phrase: "(1949"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.171: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.172: 20, 1-9 2. 

Phrase: "20,"

Phrase: "1-9 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0580272:1/2 [Intellectual Product]
   913   C1519043:1-2 [Research Activity]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]
Processing 00000000.tx.173: Duckworth, W. 

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.174: C., Bennett, R. 

Phrase: "C., Bennett,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.175: G., and Hamel, F. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hamel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.176: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.177: (1998) Endocr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.178: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.179: 19, 608-624[Abstract/Free FullText] 3. 

Phrase: "19,"

Phrase: "608-624"

Phrase: "[Abstract/Free FullText"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.180: Seta, K. 

Phrase: "Seta,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.181: A., and Roth, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.182: A. 

Phrase: "A."
Processing 00000000.tx.183: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.184: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.185: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.186: Commun. 

Phrase: "Commun."
Processing 00000000.tx.187: 231, 167-171[CrossRef][Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "231,"

Phrase: "167-171"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.188: Vekrellis, K., Ye, Z., Qiu, W. 

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.189: Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. 

Phrase: "Q., Walsh,"

Phrase: "D."

Phrase: ","

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."

Phrase: ","

Phrase: "Chesneau,"

Phrase: "V.,"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.190: R., and Selkoe, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.191: J. 

Phrase: "J."
Processing 00000000.tx.192: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.193: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.194: 20, 1657-1665[Abstract/Free FullText] 5. 

Phrase: "20,"

Phrase: "1657-1665"

Phrase: "[Abstract/Free FullText"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.195: Qiu, W. 

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.196: Q., Walsh, D. 

Phrase: "Q., Walsh,"

Phrase: "D."
Processing 00000000.tx.197: M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. 

Phrase: "M."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.198: B., Rosner, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.199: R., Safavi, A., Hersh, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Safavi,"

Phrase: "A.,"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.200: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.201: J. 

Phrase: "J."
Processing 00000000.tx.202: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.203: Biol. 

Phrase: "Biol."
Processing 00000000.tx.204: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.205: 273, 32730-32738[Abstract/Free FullText] 6. 

Phrase: "273,"

Phrase: "32730-32738"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.206: Authier, F., Posner, B. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Posner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.207: I., and Bergeron, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.208: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.209: (1996) Clin. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.210: Invest. 

Phrase: "Invest."
Processing 00000000.tx.211: Med. 

Phrase: "Med."
Processing 00000000.tx.212: 19, 149-160[Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "19,"

Phrase: "149-160"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.213: Roth, R. 

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.214: A., Mesirow, M. 

Phrase: "A.,"

Phrase: "Mesirow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.215: L., Yokono, K., and Baba, S. 

Phrase: "L., Yokono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Baba,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.216: (1984) Endocr. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.217: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.218: 10, 101-112[Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "10,"

Phrase: "101-112"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.219: Muller, D., Schulze, C., Baumeister, H., Buck, F., and Richter, D. 

Phrase: "Muller,"

Phrase: "D."

Phrase: ","

Phrase: "Schulze,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Baumeister,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Buck,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0852885:buck [Injury or Poisoning]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Richter,"

Phrase: "D."
Processing 00000000.tx.220: (1992) Biochemistry 31, 11138-11143[Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochemistry 31,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005477:Biochemistry [Occupation or Discipline]
   861   C0450355:31 [Intellectual Product]

Phrase: "11138-11143"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.221: Garcia, J. 

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "J."
Processing 00000000.tx.222: V., Gehm, B. 

Phrase: "V., Gehm,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.223: D., and Rosner, M. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.224: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.225: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.226: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.227: 109, 1301-1307[Abstract] 10. 

Phrase: "109,"

Phrase: "1301-1307"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 10."
Processing 00000000.tx.228: Semple, J. 

Phrase: "Semple,"

Phrase: "J."
Processing 00000000.tx.229: W., Ellis, J., and Delovitch, T. 

Phrase: "W., Ellis,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Delovitch,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.230: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.231: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.232: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.233: 142, 4184-4193[Abstract/Free FullText] 11. 

Phrase: "142,"

Phrase: "4184-4193"

Phrase: "[Abstract/Free FullText"

Phrase: "] 11."
Processing 00000000.tx.234: Duckworth, W. 

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.235: C., Robert, G. 

Phrase: "C., Robert,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.236: B., and Hamel, F. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Hamel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.237: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.238: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.239: Biol. 

Phrase: "Biol."
Processing 00000000.tx.240: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.241: 269, 24575-24580[Abstract/Free FullText] 12. 

Phrase: "269,"

Phrase: "24575-24580"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.242: Kupfer, S. 

Phrase: "Kupfer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.243: R., Wilson, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wilson,"

Phrase: "E."
Processing 00000000.tx.244: M., and French, F. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "French,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.245: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.246: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.247: Biol. 

Phrase: "Biol."
Processing 00000000.tx.248: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.249: 269, 20622-20628[Abstract/Free FullText] 13. 

Phrase: "269,"

Phrase: "20622-20628"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.250: Safavi, A., Miller, B. 

Phrase: "Safavi,"

Phrase: "A.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.251: C., Cottam, L., and Hersh, L. 

Phrase: "C., Cottam,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.252: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.253: (1996) Biochemistry 35, 14318-14325[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochemistry 35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "14318-14325"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.254: Kurochkin, I. 

Phrase: "Kurochkin,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.255: V., and Goto, S. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Goto,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.256: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.257: 345, 33-37[CrossRef][Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "345,"

Phrase: "33-37"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.258: McDermott, J. 

Phrase: "McDermott,"

Phrase: "J."
Processing 00000000.tx.259: R., and Gibson, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Gibson,"

Phrase: "A."
Processing 00000000.tx.260: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.261: (1997) Neurochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.262: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.263: 22, 49-56[Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "22,"

Phrase: "49-56"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.264: Mukherjee, A., Song, E.-S., Kihiko, M., Goodman, J. 

Phrase: "Mukherjee,"

Phrase: "A.,"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "E.-S.,"

Phrase: "Kihiko,"

Phrase: "M."

Phrase: ","

Phrase: "Goodman,"

Phrase: "J."
Processing 00000000.tx.265: P., Jr., Pyrek, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Pyrek,"

Phrase: "J."
Processing 00000000.tx.266: S., Estus, S., and Hersh, L. 

Phrase: "S."

Phrase: ","

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.267: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.268: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.269: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.270: 20, 8745-8749[Abstract/Free FullText] 17. 

Phrase: "20,"

Phrase: "8745-8749"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.271: Perez, A., Morekki, L., Cresto, J. 

Phrase: "Perez,"

Phrase: "A.,"

Phrase: "Morekki,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cresto,"

Phrase: "J."
Processing 00000000.tx.272: C., and Castano, E. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Castano,"

Phrase: "E."
Processing 00000000.tx.273: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.274: (2000) Neurochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.275: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.276: 25, 247-255[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "25,"

Phrase: "247-255"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.277: Perlman, R. 

Phrase: "Perlman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.278: K., Gehm, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gehm,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.279: D., Kuo, W.-L., and Rosner, M. 

Phrase: "D."

Phrase: ","

Phrase: "Kuo,"

Phrase: "W.-L.,"

Phrase: "and"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.280: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.281: Biol. 

Phrase: "Biol."
Processing 00000000.tx.282: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.283: 268, 21538-21544[Abstract/Free FullText] 19. 

Phrase: "268,"

Phrase: "21538-21544"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.284: Perlman, R. 

Phrase: "Perlman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.285: K., and Rosner, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.286: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.287: Biol. 

Phrase: "Biol."
Processing 00000000.tx.288: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.289: 269, 33140-33145[Abstract/Free FullText] 20. 

Phrase: "269,"

Phrase: "33140-33145"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.290: Gehm, B. 

Phrase: "Gehm,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.291: D., Kuo, W.-L., Perlman, R. 

Phrase: "D."

Phrase: ","

Phrase: "Kuo,"

Phrase: "W.-L., Perlman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.292: K., and Rosner, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.293: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.294: Biol. 

Phrase: "Biol."
Processing 00000000.tx.295: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.296: 268, 7943-7948[Abstract/Free FullText] 21. 

Phrase: "268,"

Phrase: "7943-7948"

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.297: Baumeister, H., Muller, D., Rehbein, M., and Richter, D. 

Phrase: "Baumeister,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Muller,"

Phrase: "D."

Phrase: ","

Phrase: "Rehbein,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Richter,"

Phrase: "D."
Processing 00000000.tx.298: (1993) FEBS Lett. 

Phrase: "(1993"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.299: 317, 350-354 22. 

Phrase: "317,"

Phrase: "350-354 22."
Processing 00000000.tx.300: Csuhai, E., Juliano, M. 

Phrase: "Csuhai,"

Phrase: "E.,"

Phrase: "Juliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.301: A., Pyrek, J. 

Phrase: "A.,"

Phrase: "Pyrek,"

Phrase: "J."
Processing 00000000.tx.302: S., Harms, A. 

Phrase: "S."

Phrase: ","

Phrase: "Harms,"

Phrase: "A."
Processing 00000000.tx.303: C., Juliano, L., and Hersh, L. 

Phrase: "C., Juliano,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.304: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.305: (1999) Anal. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.306: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.307: 269, 149-154[CrossRef][Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "269,"

Phrase: "149-154"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.308: Cleland, W. 

Phrase: "Cleland,"

Phrase: "W."
Processing 00000000.tx.309: W. 

Phrase: "W."
Processing 00000000.tx.310: (1979) Methods Enzymol. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.311: 63, 103-137[Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "63,"

Phrase: "103-137"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.312: Chagas, J. 

Phrase: "Chagas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0697125:chaga [Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.313: R., Juliano, L., and Prado, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Juliano,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Prado,"

Phrase: "E."
Processing 00000000.tx.314: (1991) Anal. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.315: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.316: 192, 419-425[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "192,"

Phrase: "419-425"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.317: Gershkovich, A. 

Phrase: "Gershkovich,"

Phrase: "A."
Processing 00000000.tx.318: A., and Kholodovych, V. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Kholodovych,"

Phrase: "V."
Processing 00000000.tx.319: V. 

Phrase: "V."
Processing 00000000.tx.320: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.321: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.322: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.323: Methods 33, 135-162[CrossRef][Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "Methods 33,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "135-162"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.324: Schechter, I., and Berger, A. 

Phrase: "Schechter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Berger,"

Phrase: "A."
Processing 00000000.tx.325: (1967) Biochem. 

Phrase: "(1967"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.326: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.327: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.328: Commun. 

Phrase: "Commun."
Processing 00000000.tx.329: 27, 157-162[Medline] [OrderarticleviaInfotrieve] Copyright  2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "27,"

Phrase: "157-162"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2001 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

